Research Article
No access
Published Online: 22 July 2014

Worse Cardiometabolic Health in African Immigrant Men than African American Men: Reconsideration of the Healthy Immigrant Effect

Publication: Metabolic Syndrome and Related Disorders
Volume 12, Issue Number 6

Abstract

Background: The healthy immigrant effect is a phrase that has been used for decades to describe better cardiometabolic health in African immigrants than African Americans. The recent global increase in cardiometabolic diseases raises the possibility that immigrant health may be changing. Therefore, a new assessment of cardiometabolic health in African immigrants is warranted.
Methods: Glucose tolerance status, blood pressure, and visceral adipose tissue (VAT) volume were compared in 214 self-identified healthy men comprised of 138 African immigrants, 76 African Americans, mean age 36±9 years [mean±standard deviation (SD); range 20–64 years]. Insulin resistance was defined by the lowest quartile of the insulin sensitivity index (SI≤2.28 mU/L−1·min−1). The waist circumference (WC) which predicts insulin resistance was determined using receiver operating characteristic curves and the Youden index.
Results: Body mass index (BMI) and WC were lower in African immigrants than African Americans (BMI, 27.4±3.8 vs. 29.3±5.5 kg/m2, P<0.01; WC, 91±11 vs. 97±16 cm, P<0.01). However, blood pressure, fasting glucose, and 2-hr glucose were higher in the African immigrants (all P<0.01). In addition, African immigrants had a higher prevalence of previously undiagnosed diabetes (8% vs. 0%, P<0.01) and prediabetes (35% vs. 22%, P<0.01). After adjusting for WC, African immigrants had more visceral adipose tissue (VAT) than African Americans (P<0.01). Consequently, the WC that predicted insulin resistance was 92 cm in African immigrants but 102 cm in African Americans.
Conclusion: African immigrants were less obese than African Americans but had worse cardiometabolic health, specifically higher glucose levels, more hypertension, and greater visceral adiposity. Overall, the healthy immigrant effect may no longer be valid.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Venters H, Gany F. African immigrant health. J Immigr Minor Health 2011;13:333–344.
2.
Hamilton TG, Hummer RA. Immigration and the health of U.S. black adults: Does country of origin matter? Soc Sci Med 2011;73:1551–1560.
3.
Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol 2006;35:903–919.
4.
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557–567.
5.
Levitt NS. Diabetes in Africa: Epidemiology, management and healthcare challenges. Heart 2008;94:1376–1382.
6.
Mensah GA. Ischaemic heart disease in Africa. Heart 2008;94:836–843.
7.
International Diabetes Federation. IDF Diabetes Atlas, 6th ed. 2013. Available at www.idf.org/diabetesatlas
8.
Sumner AE, Sen S, Ricks M, et al. Determining the waist circumference in african americans which best predicts insulin resistance. Obesity (Silver Spring) 2008;16:841–846.
9.
Ukegbu UJ, Castillo DC, Knight MG, et al. Metabolic syndrome does not detect metabolic risk in African men living in the U.S. Diabetes Care 2011;34:2297–2299.
10.
Executive summary: Standards of medical care in diabetes—2013. Diabetes Care 2013;36(Suppl 1):S4–S10.
11.
McDowell MA, Fryar CD, Hirsch R, et al. Anthropometric reference data for children and adults: U.S. population, 1999–2002. Adv Data 2005(361):1–5.
12.
Boston RC, Stefanovski D, Moate PJ, et al. MINMOD Millennium: A computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003;5:1003–1015.
13.
Friedewald WT, Levy RI. Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
14.
Summers RM, Liu J, Sussman DL, et al. Association between visceral adiposity and colorectal polyps on CT colonography. AJR Am J Roentgenol 2012;199:48–57.
15.
Katzmarzyk PT, Heymsfield SB, Bouchard C. Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr 2013;97:480–486.
16.
Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150–1159.
17.
Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: A prospective study among Japanese Americans. Diabetes Care 2000;23:465–471.
18.
Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999;22:1808–1812.
19.
Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the risk of impaired glucose tolerance: A prospective study among Japanese Americans. Diabetes Care 2003;26:650–655.
20.
Hayashi T, Boyko EJ, Leonetti DL, et al., Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 2003;108:1718–1723.
21.
Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008;57:1269–1275.
22.
Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: Clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645–653.
23.
Bennett GG, Wolin KY, Askew S, et al. Immigration and obesity among lower income blacks. Obesity (Silver Spring) 2007;15:1391–1394.
24.
Goel MS, McCarthy EP, Phillips RS, et al. Obesity among US immigrant subgroups by duration of residence. JAMA 2004;292:2860–2867.
25.
Antecol H, Bedard K. Unhealthy assimilation: Why do immigrants converge to American health status levels? Demography 2006;43:337–360.
26.
Griffith DM, Johnson JL, Zhang R, et al. Ethnicity, nativity, and the health of American Blacks. J Health Care Poor Underserved 2011;22:142–156.
27.
Singh GK, Siahpush M, Hiatt RA, et al. Dramatic increases in obesity and overweight prevalence and body mass index among ethnic-immigrant and social class groups in the United States, 1976–2008. J Community Health 2011;36:94–110.
28.
Angel R, Guarnaccia PJ. Mind, body, and culture: Somatization among Hispanics. Soc Sci Med 1989;28:1229–1238.
29.
Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881–887.
30.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.
31.
Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008;196:696–703.
32.
Osei K, Schuster DP. Metabolic characteristics of African descendants: A comparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia 1995;38:1103–1109.
33.
Osei K, Schuster DP, Owusu SK, et al. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: Comparative studies of three populations of West African ancestry and white Americans. Metabolism 1997;46:53–58.
34.
Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 2006;29:1263–1268.
35.
Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012;307:491–497.
36.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003;290:199–206.

Information & Authors

Information

Published In

cover image Metabolic Syndrome and Related Disorders
Metabolic Syndrome and Related Disorders
Volume 12Issue Number 6August 2014
Pages: 347 - 353
PubMed: 24814168

History

Published in print: August 2014
Published online: 22 July 2014
Published ahead of print: 9 May 2014

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Michelle Y. O'Connor
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Caroline K. Thoreson
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Madia Ricks
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Amber B. Courville
Nutrition Department of the Clinical Center, National Institutes of Health, Bethesda, Maryland.
Francine Thomas
Radiology Department of the Clinical Center, National Institutes of Health, Bethesda, Maryland.
Jianhua Yao
Radiology Department of the Clinical Center, National Institutes of Health, Bethesda, Maryland.
Peter T. Katzmarzyk
Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana.
Anne E. Sumner
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Notes

Address correspondence to:Anne E. Sumner, MDDEOB, NIDDK, NIHBuilding 10-CRC, Room 6-5940, MSC 16129000 Rockville PikeBethesda, MD 20892-1612E-mail: [email protected]

Author Disclosure Statement

None of the authors have any conflicts of interest to disclose.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top